Clin2
NCT07578363Possibly a fitNot yet recruiting

Eye drops for reducing eye redness in adults

Ocular Hyperemia

Part of Eyes & vision clinical trials.

This study tests an experimental eye drop to see if it can reduce eye redness compared to a placebo drop. If you often use redness relief drops or would like to, this trial might help you find a new option.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
178 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are an adult who can sign a consent form and attend all study visits.
  • You have used eye redness relief drops in the past 6 months, or you are interested in using over-the-counter redness relief drops, or your doctor thinks they would help you.
  • Your eye redness level must be at least 0.5 on a 5-point scale in one eye at the first visit, and later higher than 1 unit in both eyes before the treatment starts.
  • You have not had eye surgery in the last 6 months.
  • You do not have any eye condition, medication use, or health issue that the study doctors decide would make it unsafe or affect the results.
  • Your blood pressure, pulse, and eye pressure must be within normal ranges as defined by the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07531043Not yet recruiting· Phase 3
Eye drops for red eyes in adults

This trial tests an eye drop that may reduce redness in adults who often use redness relief drops or are interested in them. If you qualify, you might get either the study drop or a placebo to see if it works.

Fort Worth, Texas
NCT07209410Recruiting· Phase 4
Eye drops to reduce redness from glaucoma treatment

This trial tests if adding brimonidine eye drops can reduce eye redness caused by the glaucoma drops you are currently taking. It may help if you have been using netarsudil/latanoprost drops and have noticed redness.

Kansas City, Missouri
NCT07778888Not yet recruiting· Phase 2
Adjustable treatment for eye redness in dry eye disease

This study tests an eye drop that may reduce redness and irritation in people with dry eye disease. It looks at different doses to find the best treatment for each person.

NCT04007276Not yet recruiting· Phase 4
Check if Lumify changes eye redness and pressure in glaucoma

This study tests whether Lumify™ eye drops affect eye redness, eye pressure, and eyelid position in people with primary open-angle glaucoma. It may help doctors understand how “whitening” eye drops could interact with glaucoma treatment and symptoms.

New Orleans, Louisiana
NCT07764965Not yet recruiting· Phase 1
Eye drop safety study in healthy adults

This study tests a new eye drop medicine to see if it is safe and how the body handles it. It is for healthy adults only, not for treating a condition.

NCT07474883Recruiting· Early Phase 1
Timolol eye drops for red marks after acne

This trial tests if timolol eye drops, applied to the skin, can reduce red marks left by acne. It may be an option for people with acne-related redness who haven't responded to other treatments.

Ho Chi Minh City

Hear when a new Ocular Hyperemia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.